2-DE	2-dimensional electrophoresis
ADP	adenosine diphosphate
ApoA1	apolipoprotein A1
BBB	blood-brain barrier
BDI	Beck’s depression inventory
BMI	body mass index
CIMT	carotid intima-media thickness
CIS	clinically isolated syndrome
CNS	central nervous system
CPDA-1	citrate phosphate dextrose adenine-1
CRP	C-reactive protein
CSF	cerebrospinal fluid
CVD	cardiovascular disease
EDSS	expanded disability status scale
GPCRs	G-protein-coupled protease-activated receptors
GPIIb/IIIa	glycoprotein IIb/IIIa
HDL	high-density lipoprotein
IgM	immunoglobulin M
IL-6	interleukin-6
IQR	interquartile range
LDL	low-density lipoprotein
MALDI-TOF/TOF	matrix-assisted laser desorption/ionization time-of-flight/time-of-flight
miRNA	microRNA
MMP	matrix metalloproteinase
MS	multiple sclerosis
PAGs	platelet aggregates
PAP	plasmin–anti-plasmin
PAR1	protease-activated receptor 1
PBMCs	peripheral blood mononuclear cells
PF4	platelet factor 4
PLAs	platelet-leukocyte aggregates
PMPs	platelet microparticles
PP MS	primary progressive multiple sclerosis
PRP	platelet-rich plasma
PSGL-1	P-selectin glycoprotein ligand 1
Rho	Spearman’s rank correlation
RR MS	relapsing-remitting multiple sclerosis
RT-qPCR	quantitative Real-Time polymerase chain reaction
SP MS	secondary progressive multiple sclerosis
TAT	thrombin–anti-thrombin
TNF-α	tumor necrosis factor α
TRAP-6	thrombin receptor-activating peptide 6
vWF	von Willebrand factor
α2M	α-2-macroglobulin
β-TG	β-thromboglobulin